Priority Date: 03.05.06 (US 20060796867P)

CD40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity

  • Application ID: EP13152053
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicant

Attorney

operating since 1894
Headquarter in London and 5 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 133 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 03.05.2006 - Priority Date (US 20060796867P)
  • 08.05.2013 - Publication A1 (EP2589654)